New decision aid aims to improve opioid treatment choices
NCT ID NCT03568552
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a patient decision aid designed to help adults with opioid use disorder choose the best medication-assisted treatment for them. Over 7,500 people took part, and researchers tracked their drug use, treatment retention, and health outcomes for up to 24 months. The goal was to see if the tool improves treatment success and reduces opioid use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCLA Integrated Substance Abuse Programs
Los Angeles, California, 90049, United States